by Peter MacCallum Cancer Centre Credit: Pixabay/CC0 Public Domain All patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed or was no longer responding to conventional treatments, including CAR T-cell therapy. Peter Mac treated the first patients in the world with glofitamab and was...
